These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18451153)

  • 1. Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5.
    Shi J; Orth JD; Mitchison T
    Cancer Res; 2008 May; 68(9):3269-76. PubMed ID: 18451153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models.
    Ye XS; Fan L; Van Horn RD; Nakai R; Ohta Y; Akinaga S; Murakata C; Yamashita Y; Yin T; Credille KM; Donoho GP; Merzoug FF; Li H; Aggarwal A; Blanchard K; Westin EH
    Mol Cancer Ther; 2015 Nov; 14(11):2463-72. PubMed ID: 26304237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
    Chin GM; Herbst R
    Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells.
    Marcus AI; Peters U; Thomas SL; Garrett S; Zelnak A; Kapoor TM; Giannakakou P
    J Biol Chem; 2005 Mar; 280(12):11569-77. PubMed ID: 15653676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly.
    Huang HC; Shi J; Orth JD; Mitchison TJ
    Cancer Cell; 2009 Oct; 16(4):347-58. PubMed ID: 19800579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate.
    Orth JD; Tang Y; Shi J; Loy CT; Amendt C; Wilm C; Zenke FT; Mitchison TJ
    Mol Cancer Ther; 2008 Nov; 7(11):3480-9. PubMed ID: 18974392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinesin motor proteins as targets for cancer therapy.
    Huszar D; Theoclitou ME; Skolnik J; Herbst R
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):197-208. PubMed ID: 19156502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.
    Asraf H; Avunie-Masala R; Hershfinkel M; Gheber L
    PLoS One; 2015; 10(6):e0129255. PubMed ID: 26035434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells.
    Nakai R; Iida S; Takahashi T; Tsujita T; Okamoto S; Takada C; Akasaka K; Ichikawa S; Ishida H; Kusaka H; Akinaga S; Murakata C; Honda S; Nitta M; Saya H; Yamashita Y
    Cancer Res; 2009 May; 69(9):3901-9. PubMed ID: 19351824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mitosis for anti-cancer therapy.
    Sudakin V; Yen TJ
    BioDrugs; 2007; 21(4):225-33. PubMed ID: 17628120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eg5 targeting agents: From new anti-mitotic based inhibitor discovery to cancer therapy and resistance.
    Garcia-Saez I; Skoufias DA
    Biochem Pharmacol; 2021 Feb; 184():114364. PubMed ID: 33310050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH; Jiang JD; Holland JF; Perez-Soler R
    Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
    Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
    Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic.
    Shi J; Mitchison TJ
    Endocr Relat Cancer; 2017 Sep; 24(9):T83-T96. PubMed ID: 28249963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPUYJ039, a newly synthesized benzimidazole-based compound, is proved to be a novel inducer of apoptosis in HCT116 cells with potent KSP inhibitory activity.
    Jiang C; Yang L; Wu WT; Guo QL; You QD
    J Pharm Pharmacol; 2011 Nov; 63(11):1462-9. PubMed ID: 21988427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intermittent live cell imaging screen for siRNA enhancers and suppressors of a kinesin-5 inhibitor.
    Tsui M; Xie T; Orth JD; Carpenter AE; Rudnicki S; Kim S; Shamu CE; Mitchison TJ
    PLoS One; 2009 Oct; 4(10):e7339. PubMed ID: 19802393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle.
    Zhu Y; Zhou Y; Shi J
    Cell Cycle; 2014; 13(11):1756-64. PubMed ID: 24694730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenothiazine and carbazole-related compounds inhibit mitotic kinesin Eg5 and trigger apoptosis in transformed culture cells.
    Okumura H; Nakazawa J; Tsuganezawa K; Usui T; Osada H; Matsumoto T; Tanaka A; Yokoyama S
    Toxicol Lett; 2006 Sep; 166(1):44-52. PubMed ID: 16814965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of kinesin motor inhibitors and their clinical progress.
    Voultsiadou A; Sarli V
    Rev Recent Clin Trials; 2011 Sep; 6(3):271-7. PubMed ID: 21682672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Lamin A/C Expression Is a Key Determinant of Paclitaxel Sensitivity.
    Smith ER; Leal J; Amaya C; Li B; Xu XX
    Mol Cell Biol; 2021 Jun; 41(7):e0064820. PubMed ID: 33972393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.